Log in
Enquire now
Axiogenesis

Axiogenesis

Axiogenesis was a company that engaged in the development and commercialization of in vitro models of healthy and diseased cell types and tissue.

OverviewStructured DataIssuesContributors

Contents

axiogenesis.com
Is a
Organization
Organization
Company
Company

Company attributes

Industry
Pharmacy
Pharmacy
0
Biotechnology
Biotechnology
Biology
Biology
Genetics
Genetics
Technology
Technology
Location
Cologne
Cologne
B2X
B2C
B2C
CEO
‌
Heribert Bohlen
Founder
‌
Heribert Bohlen
Legal Name
Axiogenesis AG
Number of Employees (Ranges)
11 – 50
Full Address
Nattermannallee 1, Building S20 50829 Cologne Germany
Investors
Sino-German Fund
Sino-German Fund
Founded Date
2000
0
Latest Funding Round Date
May 2016
Latest Funding Type
Series A
Series A
Patents Assigned (Count)
1

Other attributes

Company Operating Status
Closed

Axiogenesis was a company that engaged in the development and commercialization of in vitro models of healthy and diseased cell types and tissue. It developed stem cell-derived, in vitro differentiated cardiomyocytes, neurons and other cell types.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like Axiogenesis

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Pricing
  • Enterprise

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.